-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Avalo Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2019 to Q2 2024.
- Avalo Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $9.58M, a 22.9% increase year-over-year.
- Avalo Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $54.6M, a 44.9% increase year-over-year.
- Avalo Therapeutics, Inc. annual Costs and Expenses for 2023 was $29.3M, a 47.2% decline from 2022.
- Avalo Therapeutics, Inc. annual Costs and Expenses for 2022 was $55.5M, a 36.6% decline from 2021.
- Avalo Therapeutics, Inc. annual Costs and Expenses for 2021 was $87.5M, a 10% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)